TITLE

Dyslipidemia in primary care - prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)

AUTHOR(S)
Steinhagen-Thiessen, Elisabeth; Bramlage, Peter; Lösch, Christian; Hauner, Hans; Schunkert, Heribert; Vogt, Anja; Wasem, Jürgen; Jöckel, Karl-Heinz; Moebus, Susanne
PUB. DATE
January 2008
SOURCE
Cardiovascular Diabetology;2008, Vol. 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Current guidelines from the European Society of Cardiology (ESC) define low thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol (LDL-C) to guide treatment. Although being mainly a prevention tool, its thresholds are difficult to meet in clinical practice, especially primary care. Methods: In a nationwide study with 1,511 primary care physicians and 35,869 patients we determined the prevalence of dyslipidemia, its recognition, treatment, and control rates. Diagnosis of dyslipidemia was based on TC and LDL-C. Basic descriptive statistics and prevalence rate ratios, as well as 95% confidence intervals were calculated. Results: Dyslipidemia was highly frequent in primary care (76% overall). 48.6% of male and 39.9% of female patients with dyslipidemia was diagnosed by the physicians. Life style intervention did however control dyslipidemia in about 10% of patients only. A higher proportion (34.1% of male and 26.7% female) was controlled when receiving pharmacotherapy. The chance to be diagnosed and subsequently controlled using pharmacotherapy was higher in male (PRR 1.15; 95%CI 1.12-1.17), in patients with concomitant cardiovascular risk factors, in patients with hypertension (PRR 1.20; 95%CI 1.05-1.37) and cardiovascular disease (PRR 1.46; 95%CI 1.29-1.64), previous myocardial infarction (PRR 1.32; 95%CI 1.19-1.47), and if patients knew to be hypertensive (PRR 1.18; 95%CI 1.04-1.34) or knew about their prior myocardial infarction (PRR 1.17; 95%CI 1.23-1.53). Conclusion: Thresholds of the ESC seem to be difficult to meet. A simple call for more aggressive treatment or higher patient compliance is apparently not enough to enhance the proportion of controlled patients. A shift towards a multifactorial treatment considering lifestyle interventions and pharmacotherapy to reduce weight and lipids may be the only way in a population where just to be normal is certainly not ideal.
ACCESSION #
55716391

 

Related Articles

  • Ensuring access to cardiac rehabilitation. Ridley, Jill // Independent Nurse;11/23/2009, p26 

    This article discusses cardiac rehabilitation for patients with cardiovascular disease (CVD). Particular focus is given to the objective of a cardiac rehabilitation process and its benefits. There are four phases in a cardiac rehabilitation programme. Indications for cardiac rehabilitation are...

  • Reducing Global Risk of Ambulatory Assisted Hypertensive Patients - What Could Be Changed in the Practice of a Romanian Preventive Ambulatory System According to New Dyslipidaemia Guidelines? Preg, Z.; Kikeli, P.; Márta, Germán-Salló; Mihaela, Hubatsch; Andreea-Elena, Bocicor; László, M. I. // Acta Medica Marisiensis;2012, Vol. 58 Issue 4, p251 

    Reducing the total cardiovascular risk of hypertensive patients is one of the basic targets in hypertension management. A good lipid control is a major contributor of the global risk reduction. Purpose: To simulate the impact of the ESC/EAS 2011 guidelines for the management of dyslipidaemias on...

  • Cardiovascular Risk in Obese Hypertensive Patients Taking Various Antihypertensive Drugs. Schindler, Christoph; Bramlage, Peter; Thoenes, Martin; Bramlage, Carsten; Kirch, Wilhelm // Clinical Drug Investigation;2007, Vol. 27 Issue 10, p707 

    Objective: Obese patients often present with multiple co-morbid conditions, including hypertension, which are associated with an increased cardiovascular (CV) risk. We aimed to assess the risk factor profiles of primary-care patients with obesity and hypertension in order to estimate their fatal...

  • Stents: new findings could dramatically change the market.  // PharmaWatch: Monthly Review;Oct2007, Vol. 6 Issue 10, p13 

    The article focuses on the study conducted by the European Society of Cardiology, which suggests that the mortality risk posed by stent thrombosis is increased five-fold for patients with ST-elevation myocardial infarction who receive drug-eluting stents (DES), compared to bare-metal stents. If...

  • The Munich Myocardial Infarction Registry. Schnell, Oliver; Otter, Wolfgang; Standl, Eberhard // Diabetes Care;Nov2009 Supplement, Vol. 32, pS326 

    The article focuses on the Munich Myocardial Infarction Registry which documents and assesses the management of acute myocardial infarction among hospital patients with diabetes. The registry confirmed that early treatment approaches for diabetes such as coronary angiography and stenting were...

  • Absolute Cardiovascular Disease Risk and Shared Decision Making in Primary Care: A Randomized Controlled Trial. Krones, Tanja; Keller, Heidemarie; Sönnichsen, Andreas; Sadowski, Eva-Maria; Baum, Erika; Wegscheider, Karl; Rochon, Justine; Donner-Banzhoff, Norbert // Annals of Family Medicine;May/Jun2008, Vol. 6 Issue 3, p218 

    The article discusses the effect of promoting effective communication of absolute cardiovascular disease (CVD) risk and shared decision making in primary care. It stresses the result where intervention patients were significantly more satisfied with process and result. It notes that during...

  • GP Registrar: Keeping cholesterol down. Newson, Louise // GP: General Practitioner;4/15/2005, p78 

    The article reports that in Great Britain it is estimated that cholesterol levels greater than 5.2 mmol/l are a contributory factor in 46 per cent of CHD deaths. Overwhelming evidence suggests statins are highly beneficial for both primary and secondary prevention of CHD. Target cholesterol...

  • CLINICAL CLIPS. Paist, Scott S.; Mintz, Matthew; Beck, Jonathan D.; Chambers, Christopher V.; Nicklin, David // Patient Care for the Nurse Practitioner;Mar2005, Vol. 8 Issue 3, p11 

    The article presents several abstracts of studies on patient care including Parents are lightweights against childhood obesity, A. N. Jeffery et al, Minimizing cardiovascular problems in older women with hypertension, by S. Wassertheil-Smoller, and A national survey of primary care physician's...

  • Newer Combined (ESC & EASD) 2013 guidelines for Diabetes Mellitus and Cardiovascular Disease. Lazaros, George // Hospital Chronicles;2014 Supplement 1, Vol. 9, p119 

    The article discusses the combined 2013 guidelines from the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) covering diabetes mellitus (DM) and cardiovascular disease (CVD). Topics discussed include diabetes prevention in patients with impaired...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics